Table 1.
Interpretation of molecular, serological and clinical examination.
| rRT–PCR results | Serology results (IgM i/lub IgG) | Risk of infection |
Interpretation | |
|---|---|---|---|---|
| High | Low | |||
| positive | IgM (+) i IgG (−) | + | – | early stage of infection |
| positive | IgM (+) i IgG (+) | + | – | active phase of infection |
| positive | IgM (−) i IgG (+) | + | – | late stage of infection, recurrent stage of infection |
| positive | IgM (+) lub IgG (+) | – | + | oligosymptomatic or asymptomatic infection, false–positive rRT–PCR, false–positive serology |
| positive | IgM (−) i IgG (−) | + | – | “window period” |
| positive | IgM (−) i IgG (−) | – | + | “window period”with oligosymptomatic or asymptomatic infection false–positive rRT–PCR |
| negative | IgM (+) i IgG (−) | + | – | early stage of infection, false–negative rRT–PCR |
| negative | IgM (−) i IgG (+) | + | – | late stage of infection, false–negative rRT–PCR |
| negative | IgM (−) i IgG (+) | – | + | past infection |
| negative | IgM (+) i IgG (+) | – | + | convalescence, false–negative rRT–PCR |
| negative | IgM (−) i IgG (−) | + | – | “window period”, false–negative rRT–PCR |
“+” positive result or present risk; “−” negative result or absent risk.